Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Diabetes Self-Care boosted by empowerment classes, small study suggests

NCT ID NCT07524166

Disease control Sponsor: Eotvos Lorand University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a six-week empowerment-based health education program could improve self-management in 50 adults with type 2 diabetes. Participants learned about diabetes, diet, and physical activity through group activities and discussions. The goal was to see if this approach could lower blood sugar levels and improve knowledge, confidence, and daily self-care behaviors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Empowerment-Based Health Education
What this could lead to
If successful, this approach could offer a practical, low-cost way to help people with type 2 diabetes improve their blood sugar control and daily self-care.
What could go wrong
This is a small, completed study with only 50 participants, so results may not apply to everyone. The education program's long-term benefits and impact on complications are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Aug 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 100 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. diagnosed with T2DM according to clinical record; 2. aged 40 years or older; 3. duration of diabetes of at least 6 months; 4. ability to communicate and complete questionnaires independently; 5. provision of written informed consent. Exclusion criteria: 1. presence of severe diabetes complications (e.g., renal failure, proliferative retinopathy, severe neuropathy); 2. diagnosis with other major chronic illnesses (e.g., cancer, severe heart failure); 3. pregnancy or lactation; 4. participation in other interventional studies during the trial period; 5. cognitive or psychiatric disorders that would impede participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabete mellitus are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabete mellitus Diabetes Diabetes mellitus type 2

Contacts and locations

Locations

  • Jiaxing University

    Jiaxing, Zhejiang, 314001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.